Literature DB >> 2892933

(Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.

J Alexander1, R Cargill, S R Michelson, H Schwam.   

Abstract

(Acyloxy)alkyl carbamates of the type R1R2N-CO-O-CHR3-OCO-R4 are described as novel bioreversible prodrugs for primary and secondary amines. These were prepared either by a one-step reaction involving nucleophilic attack on p-nitrophenyl alpha-(acyloxy)alkyl carbonates with displacement of p-nitrophenol or by reaction of alpha-haloalkyl carbamates with silver or mercury salts of carboxylic acids. Enzymatic hydrolysis of the ester bond in these ester carbamates leads to a cascade reaction resulting in rapid regeneration of the parent amine. Permeability measurements of such nonionic derivatives of atenolol, betaxolol, pindolol, propranolol, and timolol through fuzzy rat skin and rabbit cornea mounted on diffusion cells show that derivatization of the hydrophilic beta-blockers results in several-fold increase in permeation through these biological membranes. However, prodrug modification of the lipophilic beta-blockers leads to little advantage in permeability characteristics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892933     DOI: 10.1021/jm00397a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution.

Authors:  L C Yuan; T C Dahl; R Oliyai
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

Review 2.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

3.  Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.

Authors:  J P Shaw; C M Sueoko; R Oliyai; W A Lee; M N Arimilli; C U Kim; K C Cundy
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

4.  Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.

Authors:  André E Nel; Kuo-Ching Mei; Yu-Pei Liao; Xiangsheng Liu
Journal:  ACS Nano       Date:  2022-03-29       Impact factor: 18.027

5.  Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.

Authors:  M Safadi; R Oliyai; V J Stella
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages.

Authors:  E P Stirchak; J E Summerton; D D Weller
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

7.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

8.  A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.

Authors:  Regan J Anderson; Ching-wen Tang; Naomi J Daniels; Benjamin J Compton; Colin M Hayman; Karen A Johnston; Deborah A Knight; Olivier Gasser; Hazel C Poyntz; Peter M Ferguson; David S Larsen; Franca Ronchese; Gavin F Painter; Ian F Hermans
Journal:  Nat Chem Biol       Date:  2014-10-05       Impact factor: 15.040

9.  Effect of potential amine prodrugs of selective neuronal nitric oxide synthase inhibitors on blood-brain barrier penetration.

Authors:  Richard B Silverman; Graham R Lawton; Hantamalala Ralay Ranaivo; Laura K Chico; Jiwon Seo; D Martin Watterson
Journal:  Bioorg Med Chem       Date:  2009-09-06       Impact factor: 3.641

Review 10.  Enzyme Models-From Catalysis to Prodrugs.

Authors:  Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.